Showing results (1481-1490 of 2,116) with videos related to
Sort By:
Pageof 212
Helicobacter|March 12, 2014
Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfectionSeung Young Kim, Jong Jin Hyun, Sung Woo Jung, et al.Helicobacter|March 7, 2008
Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pyloriAndrea Wehrens, Toni Aebischer, Thomas F Meyer, et al.Helicobacter|March 7, 2008
Prevalence and risk factors for Helicobacter pylori infection in Chinese populationsRuihua Shi, Shunfu Xu, Hongjie Zhang, et al.Helicobacter|October 23, 2018
Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trialFernando Macías-García, Iria Bastón-Rey, Daniel de la Iglesia-García, et al.Helicobacter|November 10, 2018
Recruitment of CCR6<sup>+ </sup> Foxp3<sup>+</sup> regulatory gastric infiltrating lymphocytes in Helicobacter pylori gastritisYi-Ying Wu, Chin-Tung Hsieh, Gregory J Tsay, et al.Helicobacter|March 1, 2017
Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey)Yoen-Young Chuah, Deng-Chyang Wu, Seng-Kee Chuah, et al.Helicobacter|March 17, 2017
Helicobacter pylori infection is associated with reduced prevalence of colonic diverticular diseaseLars Erik Bartels, Peter Jepsen, Anders Tøttrup, et al.Helicobacter|March 23, 2017
The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsiaHsiu-Chi Cheng, Yu-Ching Tsai, Hsiao-Bai Yang, et al.Helicobacter|March 29, 2019
The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean populationYoung Jae Kwon, Nayoung Kim, Sung Min Baek, et al.Helicobacter|March 16, 2019
Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: Overcoming controversies and concernsMasumi Okuda, Yingsong Lin, Chaochen Wang, et al.Pageof 212